Research ArticleOncology
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer
Antonio Avallone, Luigi Aloj, Biagio Pecori, Corradina Caracò, Alfonso De Stefano, Fabiana Tatangelo, Lucrezia Silvestro, Vincenza Granata, Francesco Bianco, Carmela Romano, Francesca Di Gennaro, Alfredo Budillon, Antonella Petrillo, Paolo Muto, Gerardo Botti, Paolo Delrio and Secondo Lastoria
Journal of Nuclear Medicine November 2019, 60 (11) 1560-1568; DOI: https://doi.org/10.2967/jnumed.118.222604
Antonio Avallone
1Experimental Clinical Abdominal Oncology, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Luigi Aloj
2Nuclear Medicine, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Biagio Pecori
3Radiotherapy, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Corradina Caracò
2Nuclear Medicine, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Alfonso De Stefano
1Experimental Clinical Abdominal Oncology, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Fabiana Tatangelo
4Pathology, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Lucrezia Silvestro
1Experimental Clinical Abdominal Oncology, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Vincenza Granata
5Radiology, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Francesco Bianco
6Colorectal Oncological Surgery, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy; and
Carmela Romano
1Experimental Clinical Abdominal Oncology, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Francesca Di Gennaro
2Nuclear Medicine, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Alfredo Budillon
7Experimental Pharmacology, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Antonella Petrillo
5Radiology, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Paolo Muto
3Radiotherapy, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Gerardo Botti
4Pathology, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Paolo Delrio
6Colorectal Oncological Surgery, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy; and
Secondo Lastoria
2Nuclear Medicine, IRCCS Istituto Nazionale Tumori “Fondazione Giovanni Pascale,” Naples, Italy
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 11
November 1, 2019
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer
Antonio Avallone, Luigi Aloj, Biagio Pecori, Corradina Caracò, Alfonso De Stefano, Fabiana Tatangelo, Lucrezia Silvestro, Vincenza Granata, Francesco Bianco, Carmela Romano, Francesca Di Gennaro, Alfredo Budillon, Antonella Petrillo, Paolo Muto, Gerardo Botti, Paolo Delrio, Secondo Lastoria
Journal of Nuclear Medicine Nov 2019, 60 (11) 1560-1568; DOI: 10.2967/jnumed.118.222604
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer
Antonio Avallone, Luigi Aloj, Biagio Pecori, Corradina Caracò, Alfonso De Stefano, Fabiana Tatangelo, Lucrezia Silvestro, Vincenza Granata, Francesco Bianco, Carmela Romano, Francesca Di Gennaro, Alfredo Budillon, Antonella Petrillo, Paolo Muto, Gerardo Botti, Paolo Delrio, Secondo Lastoria
Journal of Nuclear Medicine Nov 2019, 60 (11) 1560-1568; DOI: 10.2967/jnumed.118.222604
Jump to section
Related Articles
Cited By...
- No citing articles found.